Scienza e Tecnologia
DNA Sequencing & Next-Generation Sequencing Market is Likely to Upsurge USD 50.04 Billion Globally by 2029, Size, Share, Trends, Demand, Market Dynamics, Growth and Competitors Outlook
The market will benefit from improved reimbursement and regulatory scenarios for next-generation sequencing-based diagnostic testing. The favorable financing conditions across the world for genomics research will give attractive expansion prospects. The market expansion is accelerated by the development of cost-effective next-generation sequencing services and products for researchers.
High-throughput sequencing is another name for . NGS allows for fast base pair sequencing of DNA samples. NGS is advancing drug development and paving the way for future personalized medicine, genetic illnesses, and clinical diagnostics. Furthermore, next-generation sequencing (NGS) is a massively parallel sequencing method capable of determining the order of nucleotides in a full genome with scalability, ultra-high throughput, and rapid speed.
The modifications and automation of this technique increased sequencing data while also helping researchers to better manage time, allowing them to attain important milestones in the Human Genome Project. Sequence-based gene expression analysis is now a "digital" alternative to analogue techniques. Genome sequencing has improved to the point where it is now simple and accurate. In the near future, these technical improvements are projected to enhance the size of the .
The increasing number of cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next generation sequencing and technological advancements in sequencing technologies, are all contributing to the growth of the DNA next generation sequencing market. The lack of experienced specialists, on the other hand, is likely to have a significant impact on the overall .
Over the forecast period, the need for next-generation sequencing methods will grow as R&D activities for treatments used in the treatment of genetic disorders increase. A substantial market demand will be created as R&D investments increase and the number of studies related to the treatment of among individuals grows. Governments in industrialised economies have implemented a number of programmes and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.
In 2020, the academic institutes and research centres end-use category accounted for 45 percent of the market. Hospitals choose next-generation sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, next-generation sequencing can be utilised to collect the most up-to-date data and identify transmission links in order to avoid infections across hospital settings, which will boost market revenue.
The countries covered in the are U.S., Canada and Mexico in North America , Germany , France , U.K., Netherlands , Switzerland , Belgium , Russia , Italy , Spain , Turkey , Rest of Europe in Europe , China , Japan , India , South Korea , Singapore , Malaysia , Australia , Thailand , Indonesia , Philippines , Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia , U.A.E, South Africa , Egypt , Israel , Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil , Argentina and Rest of South America as part of South America .
due to the presence of several clinical laboratories that use NGS to offer genetic testing services, which drives the regional market.
from 2022 to 2029. The presence of local companies, such as BGI Genomics, and NGS service providers including First BASE Laboratories Sdn Bhd, Macrogen Asia-Pacific Pte Ltd., and others is expected to drive the market.
1. Introduction
2. Market Segmentation
3. Executive Summary
4. Premium Insights
5. : Regulations
6. Market Overview
7. Global DNA Sequencing & Next-Generation Sequencing Market, By Component
8. Global DNA Sequencing & Next-Generation Sequencing Market, By Product
9. Global DNA Sequencing & Next-Generation Sequencing Market, By Type
10. Global DNA Sequencing & Next-Generation Sequencing Market, By Application
11. Global DNA Sequencing & Next-Generation Sequencing Market, By Technology
12. Global DNA Sequencing & Next-Generation Sequencing Market, By End User
13. Global DNA Sequencing & Next-Generation Sequencing Market, By Region
14. Global DNA Sequencing & Next-Generation Sequencing Market: Company Landscape
15. SWOT Analyses
16. Company Profile
17. Questionnaires
18. Related Reports
, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics) https://www.databridgemarketresearch.com/reports/global-next-generation-dna-sequencing-ngs-market
, By Product (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (U.S., Canada , Mexico , Germany , U.K., Italy , France , Spain , Switzerland , Russia , Turkey , Belgium , Netherlands and Rest of Europe , Japan , China , South Korea , India , Australia , Singapore , Thailand , Malaysia , Indonesia , Philippines and Rest of Asia-Pacific , Brazil and Rest of South America , South Africa and Rest of Middle East And Africa) https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market
, By Component (Second-Generation Sequencing and Third-Generation Sequencing), Product and Service (Systems, Kits, and Services), Application (Drug Discovery and Development, Agriculture & Animal Research, Diagnostics, Personalized Medicine, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals and Clinics, Clinical Laboratories, and Others), Distribution Channel (Direct Trade, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/global-whole-exome-sequencing-market
, By Type (Targeted Sequencing/Gene Panels, RNA-Sequencing, De Novo Sequencing, Exome Sequencing, CHiP-Sequencing, Whole-genome Sequencing, Methyl-Sequencing, Other Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nanopore Sequencing), Application (Diagnostics, Drug Discovery, Biomarker Discovery, Microbial Genetics, Agriculture, and Animal Research, Other Applications), End User (Academic and Government Institutes and Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users) https://www.databridgemarketresearch.com/reports/global-ngs-services-market
, By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nano Pore Sequencing and Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural and Animal Research and Other Applications), End User (Academic Institutes and Research Centres, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies and Other End Users), Service (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Animal and Plant Sequencing and Other Sequencing Services), Workflow (Pre-Sequencing, Sequencing and Data Analysis), Country (U.S., Canada , Mexico , Germany , Italy , U.K., France , Spain , Netherlands , Belgium , Switzerland , Turkey , Russia , Rest of Europe , Japan , China , India , South Korea , Australia , Singapore , Malaysia , Thailand , Indonesia , Philippines , Rest of Asia- Pacific , Brazil , Argentina , Rest of South America , South Africa , Saudi Arabia , UAE, Egypt , Israel , Rest of Middle East and Africa ) https://www.databridgemarketresearch.com/reports/global-clinical-next-generation-sequencing-nsg-testing-market
, By Product (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (U.S., Canada , Mexico ) https://www.databridgemarketresearch.com/reports/north-america-next-generation-sequencing-ngs-market
, By Product (Kits and Reagents, Sequencing and Data Analytics Services, Instruments, Consumables, Others), Application (Environmental, Human Health, Agriculture, Biotechnology, Biofuel, Others), End Users (Pharmaceutical Industries, Biotechnology Companies, Research Laboratories, Pathology Laboratories, Academic and Research Institutes, Others), Country (U.S., Canada , Mexico , Germany , Italy , U.K., France , Spain , Netherland, Belgium , Switzerland , Turkey , Russia , Rest of Europe , Japan , China , India , South Korea , Australia , Singapore , Malaysia , Thailand , Indonesia , Philippines , Rest of Asia-Pacific , Brazil , Argentina , Rest of South America , South Africa , Saudi Arabia , UAE, Egypt , Israel , Rest of Middle East & Africa ) https://www.databridgemarketresearch.com/reports/global-sequencing-driven-metagenomics-market
, By Sequencing Technology (High-Throughput Sequencing, Sanger Sequencing, SBL, RNA Sequencing, SBS, Third-Generation Sequencing, Whole Genome Sequencing, Targeted Gene Sequencing, Shotgun Sequencing, Others), Component (Reagents & Kits, Instruments), Targeted Disease (CNS Diseases, Gastrointestinal Diseases, Oncology, Infectious Diseases, Others), Application (Personalized Medicine, Genetic Screening, Therapeutic, Drug & Biomarker Discovery, Disease Diagnosis Research, Others), Research Type (Outsourced, In-House), End-User (Pharmaceutical & Biotechnology, Academic Centers & Research Institutes, CROs, Others), Laboratory Type (Dry Lab, Wet Lab), Country (U.S., Canada , Mexico , Germany , Italy , U.K., France , Spain , Netherland, Belgium , Switzerland , Turkey , Russia , Rest of Europe , Japan , China , India , South Korea , Australia , Singapore , Malaysia , Thailand , Indonesia , Philippines , Rest of Asia- Pacific , Brazil , Argentina , Rest of South America , South Africa , Saudi Arabia , UAE, Egypt , Israel , Rest of Middle East & Africa ) https://www.databridgemarketresearch.com/reports/global-microbiome-sequencing-market
, By Technology (Sanger Sequencing, NGS, Third Generation Sequencing), Type (Library Kits, Template Kits, Control Kits, Sequencing Kits, Others), Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others), End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), Country (U.S., Canada , Mexico , Germany , Italy , U.K., France , Spain , Netherland, Belgium , Switzerland , Turkey , Russia , Rest of Europe , Japan , China , India , South Korea , Australia , Singapore , Malaysia , Thailand , Indonesia , Philippines , Rest of Asia- Pacific , Brazil , Argentina , Rest of South America , South Africa , Saudi Arabia , UAE, Egypt , Israel , Rest of Middle East & Africa ) https://www.databridgemarketresearch.com/reports/global-sequencing-reagents-market
, By Product (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country ( Germany , U.K., Italy , France , Spain , Switzerland , Russia , Turkey , Belgium , Netherlands and Rest of Europe ) https://www.databridgemarketresearch.com/reports/europe-next-generation-sequencing-ngs-market
, By Product (Consumables, Systems and Software, Services), Technology (PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, Others), Application (Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research, Others), End-User (Research Centers, Academic and Government Institutes, Hospitals & Clinics, Pharmaceutical and Biotechnology Companies, Others), Country (U.S., Canada , Mexico , Germany , Italy , U.K., France , Spain , Netherland, Belgium , Switzerland , Turkey , Russia , Rest of Europe , Japan , China , India , South Korea , Australia , Singapore , Malaysia , Thailand , Indonesia , Philippines , Rest of Asia-Pacific , Brazil , Argentina , Rest of South America , South Africa , Saudi Arabia , UAE, Egypt , Israel , Rest of Middle East & Africa ) https://www.databridgemarketresearch.com/reports/global-genome-sequencing-market
set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune .
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. .
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong : +852 8192 7475
Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/dna-sequencing--next-generation-sequencing-market-is-likely-to-upsurge-usd-50-04-billion-globally-by-2029--size-share-trends-demand-market-dynamics-growth-and-competitors-outlook-301679853.html